A Review of Advancements and Evidence Gaps in Diabetic Retinopathy Screening Models
Elizabeth Pearce,1 Sobha Sivaprasad1,2 1Department of Ocular Biology, Institute of Ophthalmology, University College London, London, UK; 2Medical Retina Department, NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UKCorrespondence: Sobha SivaprasadNIHR Moorfields Biomedic...
Enregistré dans:
Auteurs principaux: | Pearce E, Sivaprasad S |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4ff958152c15437faafaecdd9f7fbd8c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy
par: Sakamoto M, et autres
Publié: (2018) -
Natural History of Diabetic Retinopathy Through Retrospective Analysis in Type 2 Diabetic Patients—An Exploratory Study
par: Mehak Gupta, et autres
Publié: (2021) -
Subthreshold microsecond laser for proliferative diabetic retinopathy: a randomized pilot study
par: Jhingan M, et autres
Publié: (2018) -
Visual evoked potentials after panretinal photocoagulation in patients with proliferative diabetic retinopathy
par: Amini Vishte R, et autres
Publié: (2019) -
Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab
par: Shakarchi FI, et autres
Publié: (2018)